-
Danicopan in Addition to the Component 5 Inhibitor C5i Ravulizumab for the Treatment of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Residual Hemolytic Anemia in Greece: A Cost Utility Analysis
Sep 9, 2025, 16:22 PM -
From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe
Sep 9, 2025, 16:22 PM -
Number of Inquiries for a Second Course of Teprotumumab in the US Over Four Years
Sep 9, 2025, 16:22 PM -
Enhancing Patient Engagement in Consensus Development: Global Insights From a Targeted Review of Digital Platforms and Methods
Sep 9, 2025, 16:22 PM -
Long-Term HTA Trends in Patient Organization Submissions to the NCPE and Future Perspectives
Sep 9, 2025, 16:22 PM -
Impact of the Decline in the Number of Community Dermatologists in France on Treatment of Actinic Keratosis (EPIKA Study)
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of 68-Ga-PSMA-11 PET CT Imaging Followed by 177Lu-PSMA-617 Therapy in Metastatic Castrate-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
Real-World Evidence (RWE) and Its Impact on Scottish Medicines Consortium (SMC) Decisions: A Retrospective Review
Sep 9, 2025, 16:22 PM -
The Key Role of Social Participation in Health Technology Assessment: Experiences From South American Countries
Sep 9, 2025, 16:22 PM -
Humanistic and Financial Burden Experienced by Nonprofessional Care Partners of Patients With Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease: Results From a Real-World Survey in Spain
Sep 9, 2025, 16:22 PM -
Health Technology Assessment (HTA) Systems and Risk Identification Strategies: A Comparative Analysis Across Western European Countries, Canada, and Australia
Sep 9, 2025, 16:22 PM -
Scientific Outcome of ISPOR Conferences: An Analysis of 67,055 Abstracts Presented at 54 ISPOR Conferences Between 2002-2024
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long-Term Prophylaxis in Hereditary Angioedema
Sep 9, 2025, 16:22 PM -
Accelerating RTOR in Oncology: The AIM Model for Agile Trial Operations
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the AlloMap® Test for the Monitoring of Patients After Heart Transplantation: Economic Evaluation Alongside the CUPIDON Trial
Sep 9, 2025, 16:22 PM -
Assessing Different Procurement Models for Automated Insulin Delivery (AID) Systems Using a Multicriteria Decision Analysis (MCDA)-Based Framework
Sep 9, 2025, 16:22 PM -
Vignette-Based Economic Models in UK HTA Submissions: Valuable Tool or Just NICE in Theory?
Sep 9, 2025, 16:22 PM -
A Critical Review of the Screening Criteria Ratings and Recommendations by the UK National Screening Committee (NSC) for 30 Adult Conditions
Sep 9, 2025, 16:22 PM -
Why Are Costs Rising? Cohort Expansion Without Impact in a Colombian Health Insurer Region
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Systematic Reviews: An Investigation Into the Impact of Eligible Studies Being Excluded by Artificial Intelligence
Sep 9, 2025, 16:22 PM